Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size, Status and Forecast 2020-2026

August 2020 | 99 pages | ID: GDF21BEB82AAEN
QYResearch

Abstracts

This report focuses on the global Bio Contract Development and Manufacturing Organizations (CDMOs) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Bio Contract Development and Manufacturing Organizations (CDMOs) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

• Lonza
• Boehringer ?Ingelheim
• Celltrion
• Fujifilm
• Selexis
• Ology Bio
• Ardena
• Catalent
• AGC
• Amgen

Market segment by Type, the product can be split into

• API Development
• Manufacturing
• Drug Delivery

Market segment by Application, split into

• Pharmaceutical Company
• Biotechnology Company
• Generic Company

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Bio Contract Development and Manufacturing Organizations (CDMOs) status, future forecast, growth opportunity, key market and key players.
• To present the Bio Contract Development and Manufacturing Organizations (CDMOs) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Bio Contract Development and Manufacturing Organizations (CDMOs) are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue
1.4 Market Analysis by Type
  1.4.1 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 API Development
  1.4.3 Manufacturing
  1.4.4 Drug Delivery
1.5 Market by Application
  1.5.1 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Application: 2020 VS 2026
  1.5.2 Pharmaceutical Company
  1.5.3 Biotechnology Company
  1.5.4 Generic Company
1.6 Coronavirus Disease 2019 (Covid-19): Bio Contract Development and Manufacturing Organizations (CDMOs) Industry Impact
  1.6.1 How the Covid-19 is Affecting the Bio Contract Development and Manufacturing Organizations (CDMOs) Industry
    1.6.1.1 Bio Contract Development and Manufacturing Organizations (CDMOs) Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Bio Contract Development and Manufacturing Organizations (CDMOs) Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Bio Contract Development and Manufacturing Organizations (CDMOs) Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Bio Contract Development and Manufacturing Organizations (CDMOs) Market Perspective (2015-2026)
2.2 Bio Contract Development and Manufacturing Organizations (CDMOs) Growth Trends by Regions
  2.2.1 Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Bio Contract Development and Manufacturing Organizations (CDMOs) Historic Market Share by Regions (2015-2020)
  2.2.3 Bio Contract Development and Manufacturing Organizations (CDMOs) Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Bio Contract Development and Manufacturing Organizations (CDMOs) Market Growth Strategy
  2.3.6 Primary Interviews with Key Bio Contract Development and Manufacturing Organizations (CDMOs) Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Bio Contract Development and Manufacturing Organizations (CDMOs) Players by Market Size
  3.1.1 Global Top Bio Contract Development and Manufacturing Organizations (CDMOs) Players by Revenue (2015-2020)
  3.1.2 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Market Share by Players (2015-2020)
  3.1.3 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Concentration Ratio
  3.2.1 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue in 2019
3.3 Bio Contract Development and Manufacturing Organizations (CDMOs) Key Players Head office and Area Served
3.4 Key Players Bio Contract Development and Manufacturing Organizations (CDMOs) Product Solution and Service
3.5 Date of Enter into Bio Contract Development and Manufacturing Organizations (CDMOs) Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Historic Market Size by Type (2015-2020)
4.2 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Forecasted Market Size by Type (2021-2026)

5 BIO CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS (CDMOS) BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application (2015-2020)
5.2 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size (2015-2020)
6.2 Bio Contract Development and Manufacturing Organizations (CDMOs) Key Players in North America (2019-2020)
6.3 North America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type (2015-2020)
6.4 North America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size (2015-2020)
7.2 Bio Contract Development and Manufacturing Organizations (CDMOs) Key Players in Europe (2019-2020)
7.3 Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type (2015-2020)
7.4 Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application (2015-2020)

8 CHINA

8.1 China Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size (2015-2020)
8.2 Bio Contract Development and Manufacturing Organizations (CDMOs) Key Players in China (2019-2020)
8.3 China Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type (2015-2020)
8.4 China Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size (2015-2020)
9.2 Bio Contract Development and Manufacturing Organizations (CDMOs) Key Players in Japan (2019-2020)
9.3 Japan Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type (2015-2020)
9.4 Japan Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size (2015-2020)
10.2 Bio Contract Development and Manufacturing Organizations (CDMOs) Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type (2015-2020)
10.4 Southeast Asia Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application (2015-2020)

11 INDIA

11.1 India Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size (2015-2020)
11.2 Bio Contract Development and Manufacturing Organizations (CDMOs) Key Players in India (2019-2020)
11.3 India Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type (2015-2020)
11.4 India Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size (2015-2020)
12.2 Bio Contract Development and Manufacturing Organizations (CDMOs) Key Players in Central & South America (2019-2020)
12.3 Central & South America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type (2015-2020)
12.4 Central & South America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Lonza
  13.1.1 Lonza Company Details
  13.1.2 Lonza Business Overview and Its Total Revenue
  13.1.3 Lonza Bio Contract Development and Manufacturing Organizations (CDMOs) Introduction
  13.1.4 Lonza Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2015-2020))
  13.1.5 Lonza Recent Development
13.2 Boehringer ?Ingelheim
  13.2.1 Boehringer ?Ingelheim Company Details
  13.2.2 Boehringer ?Ingelheim Business Overview and Its Total Revenue
  13.2.3 Boehringer ?Ingelheim Bio Contract Development and Manufacturing Organizations (CDMOs) Introduction
  13.2.4 Boehringer ?Ingelheim Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2015-2020)
  13.2.5 Boehringer ?Ingelheim Recent Development
13.3 Celltrion
  13.3.1 Celltrion Company Details
  13.3.2 Celltrion Business Overview and Its Total Revenue
  13.3.3 Celltrion Bio Contract Development and Manufacturing Organizations (CDMOs) Introduction
  13.3.4 Celltrion Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2015-2020)
  13.3.5 Celltrion Recent Development
13.4 Fujifilm
  13.4.1 Fujifilm Company Details
  13.4.2 Fujifilm Business Overview and Its Total Revenue
  13.4.3 Fujifilm Bio Contract Development and Manufacturing Organizations (CDMOs) Introduction
  13.4.4 Fujifilm Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2015-2020)
  13.4.5 Fujifilm Recent Development
13.5 Selexis
  13.5.1 Selexis Company Details
  13.5.2 Selexis Business Overview and Its Total Revenue
  13.5.3 Selexis Bio Contract Development and Manufacturing Organizations (CDMOs) Introduction
  13.5.4 Selexis Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2015-2020)
  13.5.5 Selexis Recent Development
13.6 Ology Bio
  13.6.1 Ology Bio Company Details
  13.6.2 Ology Bio Business Overview and Its Total Revenue
  13.6.3 Ology Bio Bio Contract Development and Manufacturing Organizations (CDMOs) Introduction
  13.6.4 Ology Bio Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2015-2020)
  13.6.5 Ology Bio Recent Development
13.7 Ardena
  13.7.1 Ardena Company Details
  13.7.2 Ardena Business Overview and Its Total Revenue
  13.7.3 Ardena Bio Contract Development and Manufacturing Organizations (CDMOs) Introduction
  13.7.4 Ardena Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2015-2020)
  13.7.5 Ardena Recent Development
13.8 Catalent
  13.8.1 Catalent Company Details
  13.8.2 Catalent Business Overview and Its Total Revenue
  13.8.3 Catalent Bio Contract Development and Manufacturing Organizations (CDMOs) Introduction
  13.8.4 Catalent Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2015-2020)
  13.8.5 Catalent Recent Development
13.9 AGC
  13.9.1 AGC Company Details
  13.9.2 AGC Business Overview and Its Total Revenue
  13.9.3 AGC Bio Contract Development and Manufacturing Organizations (CDMOs) Introduction
  13.9.4 AGC Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2015-2020)
  13.9.5 AGC Recent Development
13.10 Amgen
  13.10.1 Amgen Company Details
  13.10.2 Amgen Business Overview and Its Total Revenue
  13.10.3 Amgen Bio Contract Development and Manufacturing Organizations (CDMOs) Introduction
  13.10.4 Amgen Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2015-2020)
  13.10.5 Amgen Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Bio Contract Development and Manufacturing Organizations (CDMOs) Key Market Segments
Table 2. Key Players Covered: Ranking by Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue
Table 3. Ranking of Global Top Bio Contract Development and Manufacturing Organizations (CDMOs) Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of API Development
Table 6. Key Players of Manufacturing
Table 7. Key Players of Drug Delivery
Table 8. COVID-19 Impact Global Market: (Four Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Bio Contract Development and Manufacturing Organizations (CDMOs) Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Bio Contract Development and Manufacturing Organizations (CDMOs) Players to Combat Covid-19 Impact
Table 13. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Regions (2015-2020)
Table 17. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Bio Contract Development and Manufacturing Organizations (CDMOs) Market Growth Strategy
Table 23. Main Points Interviewed from Key Bio Contract Development and Manufacturing Organizations (CDMOs) Players
Table 24. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue by Players (2015-2020) (Million US$)
Table 25. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Players (2015-2020)
Table 26. Global Top Bio Contract Development and Manufacturing Organizations (CDMOs) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) as of 2019)
Table 27. Global Bio Contract Development and Manufacturing Organizations (CDMOs) by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Bio Contract Development and Manufacturing Organizations (CDMOs) Product Solution and Service
Table 30. Date of Enter into Bio Contract Development and Manufacturing Organizations (CDMOs) Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type (2015-2020) (Million US$)
Table 33. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size Share by Type (2015-2020)
Table 34. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Market Share by Type (2021-2026)
Table 35. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size Share by Application (2015-2020)
Table 36. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application (2015-2020) (Million US$)
Table 37. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size Share by Application (2021-2026)
Table 38. North America Key Players Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share (2019-2020)
Table 40. North America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type (2015-2020) (Million US$)
Table 41. North America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Type (2015-2020)
Table 42. North America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application (2015-2020) (Million US$)
Table 43. North America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Application (2015-2020)
Table 44. Europe Key Players Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share (2019-2020)
Table 46. Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Type (2015-2020)
Table 48. Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Application (2015-2020)
Table 50. China Key Players Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue (2019-2020) (Million US$)
Table 51. China Key Players Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share (2019-2020)
Table 52. China Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type (2015-2020) (Million US$)
Table 53. China Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Type (2015-2020)
Table 54. China Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application (2015-2020) (Million US$)
Table 55. China Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Application (2015-2020)
Table 56. Japan Key Players Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share (2019-2020)
Table 58. Japan Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Type (2015-2020)
Table 60. Japan Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share (2019-2020)
Table 64. Southeast Asia Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Type (2015-2020)
Table 66. Southeast Asia Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Application (2015-2020)
Table 68. India Key Players Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue (2019-2020) (Million US$)
Table 69. India Key Players Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share (2019-2020)
Table 70. India Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type (2015-2020) (Million US$)
Table 71. India Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Type (2015-2020)
Table 72. India Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application (2015-2020) (Million US$)
Table 73. India Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share (2019-2020)
Table 76. Central & South America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Type (2015-2020)
Table 78. Central & South America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Application (2015-2020)
Table 80. Lonza Company Details
Table 81. Lonza Business Overview
Table 82. Lonza Product
Table 83. Lonza Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2015-2020) (Million US$)
Table 84. Lonza Recent Development
Table 85. Boehringer ?Ingelheim Company Details
Table 86. Boehringer ?Ingelheim Business Overview
Table 87. Boehringer ?Ingelheim Product
Table 88. Boehringer ?Ingelheim Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2015-2020) (Million US$)
Table 89. Boehringer ?Ingelheim Recent Development
Table 90. Celltrion Company Details
Table 91. Celltrion Business Overview
Table 92. Celltrion Product
Table 93. Celltrion Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2015-2020) (Million US$)
Table 94. Celltrion Recent Development
Table 95. Fujifilm Company Details
Table 96. Fujifilm Business Overview
Table 97. Fujifilm Product
Table 98. Fujifilm Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2015-2020) (Million US$)
Table 99. Fujifilm Recent Development
Table 100. Selexis Company Details
Table 101. Selexis Business Overview
Table 102. Selexis Product
Table 103. Selexis Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2015-2020) (Million US$)
Table 104. Selexis Recent Development
Table 105. Ology Bio Company Details
Table 106. Ology Bio Business Overview
Table 107. Ology Bio Product
Table 108. Ology Bio Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2015-2020) (Million US$)
Table 109. Ology Bio Recent Development
Table 110. Ardena Company Details
Table 111. Ardena Business Overview
Table 112. Ardena Product
Table 113. Ardena Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2015-2020) (Million US$)
Table 114. Ardena Recent Development
Table 115. Catalent Business Overview
Table 116. Catalent Product
Table 117. Catalent Company Details
Table 118. Catalent Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2015-2020) (Million US$)
Table 119. Catalent Recent Development
Table 120. AGC Company Details
Table 121. AGC Business Overview
Table 122. AGC Product
Table 123. AGC Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2015-2020) (Million US$)
Table 124. AGC Recent Development
Table 125. Amgen Company Details
Table 126. Amgen Business Overview
Table 127. Amgen Product
Table 128. Amgen Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2015-2020) (Million US$)
Table 129. Amgen Recent Development
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Type: 2020 VS 2026
Figure 2. API Development Features
Figure 3. Manufacturing Features
Figure 4. Drug Delivery Features
Figure 5. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Application: 2020 VS 2026
Figure 6. Pharmaceutical Company Case Studies
Figure 7. Biotechnology Company Case Studies
Figure 8. Generic Company Case Studies
Figure 9. Bio Contract Development and Manufacturing Organizations (CDMOs) Report Years Considered
Figure 10. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Regions: 2020 VS 2026
Figure 12. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Players in 2019
Figure 15. Global Top Bio Contract Development and Manufacturing Organizations (CDMOs) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue in 2019
Figure 17. North America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Lonza Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Lonza Revenue Growth Rate in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2015-2020)
Figure 26. Boehringer ?Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Boehringer ?Ingelheim Revenue Growth Rate in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2015-2020)
Figure 28. Celltrion Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Celltrion Revenue Growth Rate in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2015-2020)
Figure 30. Fujifilm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Fujifilm Revenue Growth Rate in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2015-2020)
Figure 32. Selexis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Selexis Revenue Growth Rate in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2015-2020)
Figure 34. Ology Bio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Ology Bio Revenue Growth Rate in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2015-2020)
Figure 36. Ardena Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Ardena Revenue Growth Rate in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2015-2020)
Figure 38. Catalent Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Catalent Revenue Growth Rate in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2015-2020)
Figure 40. AGC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. AGC Revenue Growth Rate in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2015-2020)
Figure 42. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Amgen Revenue Growth Rate in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2015-2020)
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed